BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8944021)

  • 1. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation.
    Garkavtsev I; Kazarov A; Gudkov A; Riabowol K
    Nat Genet; 1996 Dec; 14(4):415-20. PubMed ID: 8944021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control.
    Garkavtsev I; Grigorian IA; Ossovskaya VS; Chernov MV; Chumakov PM; Gudkov AV
    Nature; 1998 Jan; 391(6664):295-8. PubMed ID: 9440695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis.
    Helbing CC; Veillette C; Riabowol K; Johnston RN; Garkavtsev I
    Cancer Res; 1997 Apr; 57(7):1255-8. PubMed ID: 9102209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas.
    Takahashi M; Ozaki T; Todo S; Nakagawara A
    Oncol Rep; 2004 Oct; 12(4):811-6. PubMed ID: 15375504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
    Jäger D; Stockert E; Scanlan MJ; Güre AO; Jäger E; Knuth A; Old LJ; Chen YT
    Cancer Res; 1999 Dec; 59(24):6197-204. PubMed ID: 10626813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of ING1 expression in sporadic breast cancer.
    Toyama T; Iwase H; Watson P; Muzik H; Saettler E; Magliocco A; DiFrancesco L; Forsyth P; Garkavtsev I; Kobayashi S; Riabowol K
    Oncogene; 1999 Sep; 18(37):5187-93. PubMed ID: 10498868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the novel tumour suppressor p33(ING1)is independent of p53.
    Cheung KJ; Bush JA; Jia W; Li G
    Br J Cancer; 2000 Dec; 83(11):1468-72. PubMed ID: 11076655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumour suppressor p33ING1 does not regulate migration and angiogenesis in melanoma cells.
    Cheung KJ; Li G
    Int J Oncol; 2002 Dec; 21(6):1361-5. PubMed ID: 12429989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumor suppressor ING1: structure and function.
    Cheung KJ; Li G
    Exp Cell Res; 2001 Aug; 268(1):1-6. PubMed ID: 11461112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
    Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p24/ING1-ALT1 and p47/ING1-ALT2, distinct alternative transcripts of p33/ING1.
    Saito A; Furukawa T; Fukushige S; Koyama S; Hoshi M; Hayashi Y; Horii A
    J Hum Genet; 2000; 45(3):177-81. PubMed ID: 10807544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumour suppressor p33ING1 does not enhance camptothecin-induced cell death in melanoma cells.
    Cheung KJ; Li G
    Int J Oncol; 2002 Jun; 20(6):1319-22. PubMed ID: 12012016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma.
    Chen B; Campos EI; Crawford R; Martinka M; Li G
    Int J Oncol; 2003 Apr; 22(4):927-31. PubMed ID: 12632089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genomic organization of the suppressor gene for tumor growth ING1].
    Baranova AV; Ivanov DV; Makeeva NV; Corcoran M; Nikitin EA; Borodina TA; Poltaraus AB; Glinshchikova OA; Sudarikov AB; Oscier D; Iankovskiĭ NK
    Mol Biol (Mosk); 2000; 34(2):263-9. PubMed ID: 10779953
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutations of the ING1 tumor suppressor gene detected in human melanoma abrogate nucleotide excision repair.
    Campos EI; Martinka M; Mitchell DL; Dai DL; Li G
    Int J Oncol; 2004 Jul; 25(1):73-80. PubMed ID: 15201991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p33ING1 mRNA and chemosensitivity in brain tumor cells.
    Tallen G; Riabowol K; Wolff JE
    Anticancer Res; 2003; 23(2B):1631-5. PubMed ID: 12820433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA.
    Cheung KJ; Mitchell D; Lin P; Li G
    Cancer Res; 2001 Jul; 61(13):4974-7. PubMed ID: 11431327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
    Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
    Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BIN1 is a novel MYC-interacting protein with features of a tumour suppressor.
    Sakamuro D; Elliott KJ; Wechsler-Reya R; Prendergast GC
    Nat Genet; 1996 Sep; 14(1):69-77. PubMed ID: 8782822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.